FLGT
Income statement / Annual
Last year (2025), Fulgent Genetics Inc's total revenue was $322.67 M,
an increase of 13.83% from the previous year.
In 2025, Fulgent Genetics Inc's net income was -$60.51 M.
See Fulgent Genetics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$322.67 M |
$283.47 M |
$289.21 M |
$618.97 M |
$992.58 M |
$421.71 M |
$32.53 M |
$21.36 M |
$18.73 M |
$18.28 M |
| Cost of Revenue |
$191.80 M
|
$176.26 M
|
$184.76 M
|
$252.07 M
|
$215.53 M
|
$89.81 M
|
$14.11 M
|
$10.69 M
|
$8.55 M
|
$6.72 M
|
| Gross Profit |
$130.88 M
|
$107.22 M
|
$104.46 M
|
$366.90 M
|
$777.05 M
|
$331.91 M
|
$18.42 M
|
$10.67 M
|
$10.18 M
|
$11.56 M
|
| Gross Profit Ratio |
0.41
|
0.38
|
0.36
|
0.59
|
0.78
|
0.79
|
0.57
|
0.5
|
0.54
|
0.63
|
| Research and Development Expenses |
$53.91 M
|
$48.82 M
|
$41.44 M
|
$28.91 M
|
$24.22 M
|
$11.58 M
|
$6.54 M
|
$5.53 M
|
$4.22 M
|
$3.56 M
|
| General & Administrative Expenses |
$116.66 M
|
$88.11 M
|
$89.00 M
|
$111.07 M
|
$50.73 M
|
$15.22 M
|
$6.41 M
|
$5.54 M
|
$5.23 M
|
$4.61 M
|
| Selling & Marketing Expenses |
$43.37 M
|
$36.25 M
|
$41.47 M
|
$38.92 M
|
$24.44 M
|
$14.95 M
|
$5.90 M
|
$4.65 M
|
$4.21 M
|
$2.47 M
|
| Selling, General & Administrative Expenses |
$160.04 M
|
$124.35 M
|
$130.47 M
|
$149.99 M
|
$75.17 M
|
$30.17 M
|
$12.31 M
|
$10.19 M
|
$9.44 M
|
$7.08 M
|
| Other Expenses |
$8.03 M
|
$7.97 M
|
$128.08 M
|
$9.47 M
|
$1.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$221.97 M
|
$181.13 M
|
$299.99 M
|
$188.37 M
|
$101.10 M
|
$41.75 M
|
$18.85 M
|
$15.72 M
|
$13.58 M
|
$10.64 M
|
| Cost And Expenses |
$413.77 M
|
$357.39 M
|
$484.74 M
|
$440.44 M
|
$316.63 M
|
$131.55 M
|
$32.96 M
|
$26.41 M
|
$22.13 M
|
$17.36 M
|
| Interest Income |
$30.92 M
|
$31.30 M
|
$21.61 M
|
$5.62 M
|
$1.35 M
|
$1.53 M
|
$837.00 K
|
$434.00 K
|
$481.00 K
|
$0.00
|
| Interest Expense |
$75.00 K
|
$170.00 K
|
$488.00 K
|
$1.01 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$5.39 M
|
| Depreciation & Amortization |
$24.12 M
|
$24.93 M
|
$26.14 M
|
$32.66 M
|
$11.00 M
|
$2.96 M
|
$2.11 M
|
$2.16 M
|
$1.73 M
|
$1.17 M
|
| EBITDA |
-$45.83 M |
-$48.99 M |
-$147.45 M |
$217.70 M |
$686.96 M |
$293.12 M |
$1.68 M |
-$2.91 M |
-$1.75 M |
$2.09 M |
| EBITDA Ratio |
-0.14
|
-0.17
|
-0.51
|
0.35
|
0.69
|
0.7
|
0.05
|
-0.14
|
-0.09
|
0.11
|
| Operating Income Ratio |
-0.28
|
-0.26
|
-0.68
|
0.29
|
0.68
|
0.69
|
-0.01
|
-0.24
|
-0.19
|
0.05
|
| Total Other Income/Expenses Net |
$21.07 M
|
$21.96 M
|
$21.44 M
|
$5.50 M
|
$5.08 M
|
-$3.32 M
|
$60.00 K
|
$434.00 K
|
$481.00 K
|
-$5.39 M
|
| Income Before Tax |
-$70.03 M
|
-$51.96 M
|
-$174.09 M
|
$184.03 M
|
$681.03 M
|
$286.84 M
|
-$368.00 K
|
-$4.64 M
|
-$3.00 M
|
-$4.47 M
|
| Income Before Tax Ratio |
-0.22
|
-0.18
|
-0.6
|
0.3
|
0.69
|
0.68
|
-0.01
|
-0.22
|
-0.16
|
-0.24
|
| Income Tax Expense |
-$8.39 M
|
-$8.14 M
|
$1.15 M
|
$42.10 M
|
$174.80 M
|
$72.53 M
|
$43.00 K
|
$36.00 K
|
-$1.02 M
|
$920.00 K
|
| Net Income |
-$60.51 M
|
-$42.71 M
|
-$167.83 M
|
$143.40 M
|
$507.36 M
|
$214.31 M
|
-$411.00 K
|
-$5.61 M
|
-$2.51 M
|
-$5.35 M
|
| Net Income Ratio |
-0.19
|
-0.15
|
-0.58
|
0.23
|
0.51
|
0.51
|
-0.01
|
-0.26
|
-0.13
|
-0.29
|
| EPS |
-1.97 |
-1.41 |
-5.63 |
4.76 |
17.13 |
9.44 |
-0.02 |
-0.25 |
-0.15 |
-0.3 |
| EPS Diluted |
-1.97 |
-1.41 |
-5.63 |
4.63 |
16.26 |
8.91 |
-0.02 |
-0.25 |
-0.15 |
-0.3 |
| Weighted Average Shares Out |
$30.78 M
|
$30.24 M
|
$29.78 M
|
$30.10 M
|
$29.41 M
|
$22.69 M
|
$18.71 M
|
$17.98 M
|
$17.74 M
|
$17.68 M
|
| Weighted Average Shares Out Diluted |
$30.78 M
|
$30.24 M
|
$29.78 M
|
$30.96 M
|
$30.98 M
|
$24.06 M
|
$18.71 M
|
$17.98 M
|
$17.74 M
|
$17.68 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
